A Study of Remimazolam Tosilate for Sedation in the Upper Gastrointestinal Endoscopy

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 11, 2023

Primary Completion Date

December 15, 2023

Study Completion Date

December 16, 2023

Conditions

Sedation in the Upper Gastrointestinal Endoscopy

Interventions

DRUG

Remimazolam Tosilate

bolus dose: 5mg，IV supplemental dose: 2.5mg，IV

Trial Locations (2)

The Affiliated Hospital Of Guizhou Medical University, Guiyang

Sichuan Provincial People's Hospital, Chengdu

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT06169995 - A Study of Remimazolam Tosilate for Sedation in the Upper Gastrointestinal Endoscopy | Biotech Hunter | Biotech Hunter